Skip to main content
BNR logo

BNR · Burning Rock Biotech Ltd

Track BNR — free
$10.19 +0.19 (+1.90%) At close · Aug 28
Market Cap
$107.47M
Shares
10.55M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.19 Open$9.79 Day$9.79–10.30 52W close$7.04–41.06 Avg vol 30d7K Short int39K · 0.4% float · 5.2d Short vol1% Last earningsMar 29, 2024 DataMay 2024–Aug 2026

Raw chart and full-history price indicators begin at the captured split on May 15, 2024; bars on opposite sides are not compared.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.4 · calm Equity put/call 0.62
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −42%
below
Price vs 50-day avg +9%
above
RSI (14) 54
neutral
MACD trend Positive
52-week position 9%
near low
Momentum
relative strength
Weak
1-month return +14%
trailing
6-month return −54%
trailing
YTD return −49%
this year
Relative strength −68%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $9 › 200d $18 — 200d above 50d
Institutional flow Accumulating
+6% holders QoQ · +3 funds added
Insider flow Accumulating
Net +$6.2M over 90 days · 0% sells
Short interest Rising
0.37% of float · ▲ +0.5% MoM · 5.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
17 holders — mid 3-yr range
Squeeze score 57
elevated · 0–100
Fundamentals
Strong
Revenue growth +9%
Y/Y
Gross margin 75%
expanding
Free cash flow $-4.8M
Buyback $10.0M
authorized
Quant / Vol
risk profile
Very High
Volatility 124%
annualized · 1-yr
Max drawdown −83%
past year
ATR 8.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Prior guidance period ended · from the Earnings Call filed Mar 31, 2023
Top-line growth · 2023 20%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−42% Bearish
Price vs 50-day avg
+9% Bullish
RSI (14)
54 Neutral
MACD trend
Positive Bullish
52-week position
9% Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $9 › 200d $18 — 200d above 50d
Institutional flow Accumulating
+6% holders QoQ · +3 funds added
Insider flow Accumulating
Net +$6.2M over 90 days · 0% sells
Short interest Rising
0.37% of float · ▲ +0.5% MoM · 5.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
17 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $7 Now $10 · 9% Range high $41
vs 200-day avg -42% vs 50-day avg +9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Diagnostics & Research — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BNR
Burning Rock Biotech Ltd
this stock
$107.47M -49.4% +9.2% 0.4%
TMO
Thermo Fisher Scientific Inc.
$230.05B +7.4% +14.5% 33.5 1.3%
DHR
Danaher Corp /De/
$151.89B -5.6% +8.5% 38.3 1.2%
NTRA
Natera, Inc.
$48.82B +42.4% -2.8% 3.0%
IQV
Iqvia Holdings Inc.
$43.79B +16.1% +41.6% 32.6 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
17
% held
16.5%
Net QoQ
+25.8K sh
Top holder
Kynam Capital Management,…
Held Float
View
Held by Funds
Fund positions
7
View
Short & Settlement
Short Interest Rising
Shares short
39.5K
Days to cover
5.2d
Change
+212 sh
View
Short Volume
Short vol %
1%
As of
Aug 28, 2026
Short Total
View
Fails to Deliver
FTD shares
31
Value
$308
As of
Jul 15, 2026
View
Off-Exchange
Off-exchange %
15.9%
Week of
Jul 20, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$6.2M
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
CNY 539.6M
Net income (FY)
CNY -55.3M
View
Buybacks
Authorized
$10.0M
View
Filings
SEC Filings
Latest
6-K
Filed
Jun 9, 2026
This year
3
View
Earnings & Events
Earnings Calls
Last call
Mar 29, 2024
View
Investor Relations
Latest news
Burning Rock Announces Founder’s…
Published
Jul 2, 2026
View

Performance

Raw-price comparisons begin at the captured split on May 15, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
BNR +4.2% +14.5% -54.2% +14.5% -49.4%
SPY +0.5% +3.0% +13.4% +3.0% +12.8%
vs SPY +3.7% +11.5% -67.6% +11.5% -62.3%

Capital returns

Buyback program · as of Jun 30, 2022
Authorized
$10.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1792267 CUSIP 12233L206 13F (30d) 15 filings 15 filers Visit website Investor relations